直 Japanese PDF Font
  • 我们的专业人员
  • 服务
  • 我们的见解
  • 办公室
  • 事务所
  • 人才招聘
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • 联邦巡回法院知识产权博客
    • INCONTESTABLE® Blog
    • Prosecution First博客
  • Events & Webinars
  • 知识产权讯息
  • 播客
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Laura P. Masurovsky

Eric Raciti and Aaron Capron on Medical Device Patents

October 6, 2014

By Eric P. Raciti; Aaron J. Capron

Medical device manufacturers are faced with unique intellectual property challenges. Manufacturers can spend years bringing a medical device to market and often rely on investors for commercialization. Potential investors carefully examine device makers' patent portfolios to ensure their intellectual property is in good order before making significant financial decisions. Eric P. Raciti and Aaron J. Capron discuss the importance of patents for medical device manufacturers and the steps they can take to enhance their marketability.

Downloadable Files

  • MedicalDevices

Related Practices

知识产权申办及组合管理

知识产权组合管理

Related Industries

生命科学

医疗设备与诊断

Related Offices

Boston, MA

Palo Alto, CA

Related Professionals

Eric P. Raciti
Partner
Boston, MA
+1 617 646 1675
Email
Aaron J. Capron
合伙人
Palo Alto, CA
+1 650 849 6680
Email

Related Insights

Conference

Patent Litigation Europe 2027

January 18-20, 2027

Amsterdam

Panel Discussion

2026 Advanced Patent Law Institute

December 3-4, 2026

Stanford

Conference

Life Sciences Patent Network North America Fall 2026

November 2-3, 2026

San Francisco

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Virtual Seminar

2026 ACC SFBA IP Symposium

September 17, 2026

Virtual

Lecture

Resolving Patent Suits Without Settlement Payments

September 3, 2026

Virtual

Articles

D. Mass. Patent Litigation Update: July 2026

August 27, 2026

Webinar

A Year of Change for Post-Grant Patent Challenges: Key PTAB and CRU Developments, and Strategic Implications

August 19, 2026

Webinar

At the PTAB Blog

Squires Issues Precedential Decision Clarifying Obviousness-Type Double Patenting Rejections

August 17, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • 隐私
  • 免责申明
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP